Komori
Financial results presentation8037KAMEI CORPORATIONTrading & Wholesale

Supplementary Explanatory Materials for the Fiscal Year Ending March 2026 Results

For the fiscal year ended March 2026, both revenue and operating profit reached record highs, resulting in higher revenue and profit. For the fiscal year ending March 2027, revenue is expected to increase, while operating profit, ordinary profit and net profit are forecast to decline.

Worth reading
51Recurring
0–100. This measures how worthwhile something is to read, not how good or bad the company is.
Direction
Mixed performance
Direction inferred from the company’s description.
Scale
1063
¥ million (year-on-year increase in operating income)
Wording
Conditional
How definitive the wording is.

Contents of this document

Financial results presentationFiscal year ending March 2026, full year10 items taken from the company’s own explanation
Financial Results Figures (The key points of this material are explained below)
Net Sales¥583,078 million+1.5%
Operating profit¥16,975 million+6.7%
Ordinary income¥18,655 million+5.1%
Net income¥11,900 million +11.3%net income attributable to owners of the parent
Selling, general and administrative expenses¥82,901 million; SG&A ratio to revenue: 14.2%
Gross Profit Margin17.1% (up 0.9 percentage points from 16.2% in the previous year)
Operating profit margin2.9% (up 0.1 percentage points from 2.8% in the previous year)
Full-year earnings forecast
Fiscal year ending March 2027
Net Sales
¥615,000 million
Operating profit
¥15,700 million
Ordinary income
¥17,500 million
Profit attributable to owners of the parent
¥11,000 million
What the company explained in this material
Breakdown of Factors Affecting the ChangeReasons cited by the Company for the change in the figures.
  • Energy+¥1.613 billion
  • Food+¥586 million
  • Construction-Related-¥165 million
  • Automotive-Related Business+¥435 million
  • Overseas and trading-¥827 million
  • Pet-related-¥80 million
  • Pharmacy-¥332 million
  • Other+¥303 million
  • Costs, etc.-¥468 million
Assumptions Underlying the Business OutlookThe assumptions used by the company in preparing its forecast.
  • Exchange rate¥155 per US dollar (¥150 in the previous fiscal year)
  • Dubai crude oil priceUS$100/bbl (US$72/bbl in the previous fiscal year)
  • Fuel oil subsidiesAssumes continuation
New initiatives
  • Introduction of a Shareholder Benefit Program
  • Launch of a next-generation agriculture business
  • Launch of the Hyaku-nen Solar Tohoku business
Key KPIsA metric the company considers important as a management benchmark.
  • Equity ratio52.4%
    Year on year against the same period last yearUp from 49.3% in the same period of the previous year
  • ROE7.2 %
    Year on year against the same period last yearUp from 7.0% in the same period of the previous year
  • ROA3.7 %
    Year on year against the same period last yearUp from 3.3% in the same period of the previous year
Unit price and quantity metricsThese figures show sales broken down by price and volume.
Information is provided on energy sales volume and selling prices, and pharmacy prescription volumes and prescription prices.
Segment results
  • Energy
    Net Sales¥279,608 million (¥3,073 million decrease year on year)
    Segment profit¥7,456 million (¥1,613 million increase year on year)
  • Food
    Net Sales¥39,141 million (¥2,462 million increase year on year)
    Segment profit¥671 million (¥586 million increase year on year)
  • Construction-Related
    Net Sales¥48,376 million (¥345 million increase year on year)
    Segment profit¥1,248 million (¥165 million decrease year on year)
  • Automotive-Related Business
    Net Sales¥80,258 million (¥6,674 million increase year on year)
    Segment profit¥4,982 million (¥435 million increase year on year)
  • Overseas and trading
    Net Sales¥91,164 million (¥1,216 million increase year on year)
    Segment profit¥4,159 million (¥827 million decrease year on year)
  • Pet-related
    Net Sales¥14,475 million (¥164 million increase year on year)
    Segment profit¥124 million (¥80 million decrease year on year)
  • Pharmacy
    Net Sales¥20,395 million (¥534 million increase year on year)
    Segment profit-¥88 million (¥332 million decrease year on year)
  • Other
    Net Sales¥9,658 million (¥476 million increase year on year)
    Segment profit¥1,489 million (¥303 million increase year on year)
Financial targets
Actual results: equity ratio of 52.4%, ROE of 7.2% and ROA of 3.7%. Target values: not disclosed
Orders received and order backlog
Order intake amount: not disclosed. The construction-related segment refers to a recovery in construction orders.
Annual Dividend
¥115 per share for the fiscal year ended March 2026 (¥50 interim, ¥65 year-end). ¥130 per share is planned for the fiscal year ending March 2027 (¥65 interim, ¥65 year-end).
Payout ratio
The policy is to gradually raise the payout ratio target from approximately 30% to approximately 40% for the fiscal year ending March 2027.
Contents of this document
ItemDetails
Document typeFinancial results presentation
Fiscal Period CoveredFiscal year ending March 2026, full year
Net Sales¥583,078 million (YoY +1.5%)
Operating profit¥16,975 million (YoY +6.7%)
Ordinary income¥18,655 million (YoY +5.1%)
Net income¥11,900 million (net income attributable to owners of the parent) (YoY +11.3%)
Gross Profit Margin17.1% (up 0.9 percentage points from 16.2% in the previous year)
Operating profit margin2.9% (up 0.1 percentage points from 2.8% in the previous year)
Selling, general and administrative expenses¥82,901 million; SG&A ratio to revenue: 14.2%
Full-year earnings forecastFiscal year ending March 2027 Net Sales ¥615,000 million / Operating profit ¥15,700 million / Ordinary income ¥17,500 million / Profit attributable to owners of the parent ¥11,000 million
Segment resultsSegment Energy / Net Sales ¥279,608 million (¥3,073 million decrease year on year) / Segment profit ¥7,456 million (¥1,613 million increase year on year), Segment Food / Net Sales ¥39,141 million (¥2,462 million increase year on year) / Segment profit ¥671 million (¥586 million increase year on year), Segment Construction-Related / Net Sales ¥48,376 million (¥345 million increase year on year) / Segment profit ¥1,248 million (¥165 million decrease year on year), Segment Automotive-Related Business / Net Sales ¥80,258 million (¥6,674 million increase year on year) / Segment profit ¥4,982 million (¥435 million increase year on year), Segment Overseas and trading / Net Sales ¥91,164 million (¥1,216 million increase year on year) / Segment profit ¥4,159 million (¥827 million decrease year on year), Segment Pet-related / Net Sales ¥14,475 million (¥164 million increase year on year) / Segment profit ¥124 million (¥80 million decrease year on year), Segment Pharmacy / Net Sales ¥20,395 million (¥534 million increase year on year) / Segment profit -¥88 million (¥332 million decrease year on year), Segment Other / Net Sales ¥9,658 million (¥476 million increase year on year) / Segment profit ¥1,489 million (¥303 million increase year on year)
Breakdown of Factors Affecting the ChangeFactors Energy / Amount +¥1.613 billion, Factors Food / Amount +¥586 million, Factors Construction-Related / Amount -¥165 million, Factors Automotive-Related Business / Amount +¥435 million, Factors Overseas and trading / Amount -¥827 million, Factors Pet-related / Amount -¥80 million, Factors Pharmacy / Amount -¥332 million, Factors Other / Amount +¥303 million, Factors Costs, etc. / Amount -¥468 million
Key KPIsIndicator name Equity ratio / Value 52.4% / Year on year against the same period last year Up from 49.3% in the same period of the previous year, Indicator name ROE / Value 7.2 % / Year on year against the same period last year Up from 7.0% in the same period of the previous year, Indicator name ROA / Value 3.7 % / Year on year against the same period last year Up from 3.3% in the same period of the previous year
Unit price and quantity metricsInformation is provided on energy sales volume and selling prices, and pharmacy prescription volumes and prescription prices.
Assumptions Underlying the Business OutlookItem Exchange rate / Value ¥155 per US dollar (¥150 in the previous fiscal year), Item Dubai crude oil price / Value US$100/bbl (US$72/bbl in the previous fiscal year), Item Fuel oil subsidies / Value Assumes continuation
Financial targetsActual results: equity ratio of 52.4%, ROE of 7.2% and ROA of 3.7%. Target values: not disclosed
Annual Dividend¥115 per share for the fiscal year ended March 2026 (¥50 interim, ¥65 year-end). ¥130 per share is planned for the fiscal year ending March 2027 (¥65 interim, ¥65 year-end).
Payout ratioThe policy is to gradually raise the payout ratio target from approximately 30% to approximately 40% for the fiscal year ending March 2027.
Orders received and order backlogOrder intake amount: not disclosed. The construction-related segment refers to a recovery in construction orders.
New initiativesIntroduction of a Shareholder Benefit Program, Launch of a next-generation agriculture business, Launch of the Hyaku-nen Solar Tohoku business
Items this document does not state (11)
Results for the three months of the current quarterProgress against full-year forecastSelf-assessment against the planNumber of stores and locationsNumber of employeesRisk amount incorporated into the outlookMedium-term management plan targetsAcquisition of treasury sharesCapital expendituresMarket Size / ShareKey points of the Q&A

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

For the fiscal year ended March 2026, growth in the automotive-related and food segments, together with higher profits in the energy, food and automotive-related segments, contributed to results. For the fiscal year ending March 2027, profit is expected to decline due to uncertainty surrounding the situation in Iran, US tariff policies, inflation and the negative impact of the exceptionally high profitability in the second half of the previous fiscal year.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Supplementary Explanatory Materials for the Fiscal Year Ending March 2026 Results | KAMEI CORPORATION (8037) timely disclosure | Komori